1Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin Noah Am,2006,20:507-544.
2Singh N, Lortholary O, Dromer F, et al. Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantatian,2008, 86:647-651.
3Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: popula- tion-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis,1999,179:449--454.
4Mirza SA, Phelan M, Rimland D. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis,2003, 36:789-794.
5Park B J, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/MDS. AIDS,2009,23:525-530.
6Tihana Bicanic, Harrison TS. Cryptococcal meningitis. British Medical Bulletin,2004,72:99-118.
7Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies forHIVassociated cryptococcal meningitis: a randomised trial. Lancet,2004,63:1764-1767.
8Sloan D, Dlamini S, Paul N, et al. Treatment of acute eryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev,2008,8 CD005647.
9Jarvis JN, Dromer F, Harrison TS, et al. Managing cryptococcosis in the immunocompromised host. Curr Opin Infect Dis,2008,21: 596-603.
10Saag MS, Graybill R J, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis,2000, 30:710-718.
二级参考文献3
1Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species[J]. Clin Infect Dis,1995, 20(6): 1526-1530.
2Sharkey PK, Graybill JR, Johnson ES et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS[J]. Clin Infect Dis,1996, 22(2): 315-321.
3Cagnoni PJ. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients[J]. J Antimicrob Chemother, 2002, 49(Suppl S1): 81-86.
4Boulware DR, Bonham SC, Meya DB, et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.J Infect Dis, 2010,202(6 ) : 962-970.
5Park BJ, Wannemuehler KA, Marston BJ,et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.AIDS, 2009,23 (4) : 525-530.
